Impairment of adenosine signaling disrupts early embryo development: unveiling the underlying mechanisms (2024)
- Authors:
- USP affiliated authors: MERKEL, CHRISTIAN ALBERT - FM ; ULRICH, ALEXANDER HENNING - IQ ; GLASER, TALITA - IQ ; BENTO, CAROLINA ADRIANE - IQ
- Unidades: FM; IQ
- DOI: 10.3389/fphar.2023.1328398
- Subjects: ADENOSINA; CÉLULAS-TRONCO; CAFEÍNA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Frontiers in Pharmacology
- ISSN: 1663-9812
- Volume/Número/Paginação/Ano: v. 14, p. 1-16 art. 1328398, 2024
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
GLASER, Talita et al. Impairment of adenosine signaling disrupts early embryo development: unveiling the underlying mechanisms. Frontiers in Pharmacology, v. 14, p. 1-16 art. 1328398, 2024Tradução . . Disponível em: https://dx.doi.org/10.3389/fphar.2023.1328398. Acesso em: 27 abr. 2024. -
APA
Glaser, T., Martins, P., Beco, R., Bento, C. A., Cappellari, A. R., Oliveira, S. L. B. de, et al. (2024). Impairment of adenosine signaling disrupts early embryo development: unveiling the underlying mechanisms. Frontiers in Pharmacology, 14, 1-16 art. 1328398. doi:10.3389/fphar.2023.1328398 -
NLM
Glaser T, Martins P, Beco R, Bento CA, Cappellari AR, Oliveira SLB de, Merkel CA, Sampaio VFA, Lameu C, Battastini AM, Ulrich H. Impairment of adenosine signaling disrupts early embryo development: unveiling the underlying mechanisms [Internet]. Frontiers in Pharmacology. 2024 ; 14 1-16 art. 1328398.[citado 2024 abr. 27 ] Available from: https://dx.doi.org/10.3389/fphar.2023.1328398 -
Vancouver
Glaser T, Martins P, Beco R, Bento CA, Cappellari AR, Oliveira SLB de, Merkel CA, Sampaio VFA, Lameu C, Battastini AM, Ulrich H. Impairment of adenosine signaling disrupts early embryo development: unveiling the underlying mechanisms [Internet]. Frontiers in Pharmacology. 2024 ; 14 1-16 art. 1328398.[citado 2024 abr. 27 ] Available from: https://dx.doi.org/10.3389/fphar.2023.1328398 - P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma
- Purinergic receptors in neurogenic processes
- Purinergic signaling: an overview
- Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration
- Using cytometry for investigation of purinergic signaling in tumor-associated macrophages
- Huntingtin protein maintains balanced energetics in mouse cardiomyocytes
- Purinergic signaling in brain physiology
- P2Y2 receptor activation promotes esophageal cancer cells proliferation via ERK1/2 pathway
- Therapeutic effects of cannabinoids and their applications in COVID-19 treatment
- Adenosinergic-dopaminergic signaling in mood disorders: a mini-review
Informações sobre o DOI: 10.3389/fphar.2023.1328398 (Fonte: oaDOI API)
Download do texto completo
Tipo | Nome | Link | |
---|---|---|---|
3187537.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas